David S. Roffman

427 total citations
20 papers, 336 citations indexed

About

David S. Roffman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and General Health Professions. According to data from OpenAlex, David S. Roffman has authored 20 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in General Health Professions. Recurrent topics in David S. Roffman's work include Heart Failure Treatment and Management (6 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). David S. Roffman is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). David S. Roffman collaborates with scholars based in United States. David S. Roffman's co-authors include Mark M. Applefeld, William P. Reed, William R. Grove, Kathryn A. Newman, Stuart T. Haines, Steven E. Linberg, William G. Kramer, Francis B. Palumbo, Stephen S. Gottlieb and Michael L. Fisher and has published in prestigious journals such as The American Journal of Medicine, The American Journal of Cardiology and American Heart Journal.

In The Last Decade

David S. Roffman

18 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David S. Roffman United States	10	215	57	48	43	41	20	336
Zachary A. Stacy United States	11	168 0.8×	11 0.2×	67 1.4×	14 0.3×	38 0.9×	25	300
Kristin Watson United States	11	103 0.5×	7 0.1×	71 1.5×	28 0.7×	26 0.6×	31	301
Kendra Wise United States	4	337 1.6×	15 0.3×	17 0.4×	16 0.4×	19 0.5×	6	420
Marco Antônio Mota Gomes Brazil	12	317 1.5×	17 0.3×	61 1.3×	19 0.4×	58 1.4×	55	481
Allan D. Kitching Canada	4	214 1.0×	9 0.2×	13 0.3×	43 1.0×	16 0.4×	6	282
Aaron Koshy United Kingdom	10	213 1.0×	33 0.6×	37 0.8×	22 0.5×	34 0.8×	27	326
Neus Badosa Spain	8	265 1.2×	25 0.4×	39 0.8×	14 0.3×	11 0.3×	17	312
Anna Donald United Kingdom	4	299 1.4×	15 0.3×	58 1.2×	11 0.3×	55 1.3×	11	404
Imran Zainal Abidin Malaysia	12	191 0.9×	9 0.2×	77 1.6×	11 0.3×	14 0.3×	48	318
Camila Pereira Leguisamo Brazil	8	103 0.5×	10 0.2×	69 1.4×	61 1.4×	6 0.1×	32	271

Countries citing papers authored by David S. Roffman

Since Specialization

Citations

This map shows the geographic impact of David S. Roffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Roffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Roffman more than expected).

Fields of papers citing papers by David S. Roffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Roffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Roffman. The network helps show where David S. Roffman may publish in the future.

Co-authorship network of co-authors of David S. Roffman

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Roffman. A scholar is included among the top collaborators of David S. Roffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Roffman. David S. Roffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Roffman, David S., et al.. (2016). Cardiovascular Pharmacology, 3rd Edition.

2.

Roffman, David S.. (2015). Developments in Oral Antiplatelet Agents for the Treatment of Acute Coronary Syndromes. Journal of Pharmacy Practice. 29(3). 239–249. 8 indexed citations

3.

Shaya, Fadia T., et al.. (2014). Incident depression increases medical utilization in Medicaid patients with hypertension. Expert Review of Cardiovascular Therapy. 13(1). 111–118. 1 indexed citations

4.

Roffman, David S.. (2010). Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention. American Journal of Health-System Pharmacy. 67(15_Supplement_7). S18–S24. 1 indexed citations

5.

Haines, Stuart T., et al.. (2009). The Impact of Advanced Pharmacy Practice Experiences on Students' Readiness for Self-directed Learning. American Journal of Pharmaceutical Education. 73(4). 65–65.

6.

Haines, Stuart T., et al.. (2009). The Impact of Advanced Pharmacy Practice Experiences on Students' Readiness for Self-directed Learning. American Journal of Pharmaceutical Education. 73(4). 65–65. 32 indexed citations

7.

Knapp, David A., David S. Roffman, & William Cooper. (2009). Growth of a Pharmacy School Through Planning, Cooperation, and Establishment of a Satellite Campus. American Journal of Pharmaceutical Education. 73(6). 102–102. 14 indexed citations

8.

Pradel, Françoise G., et al.. (2004). White Paper: Value of Specialty Certification in Pharmacy. Journal of the American Pharmacists Association. 44(5). 612–620. 34 indexed citations

9.

Roffman, David S.. (2004). High- Versus Low-Dose ACE Inhibitor Therapy in Chronic Heart Failure. Annals of Pharmacotherapy. 38(5). 831–838. 11 indexed citations

10.

Roffman, David S., Harold P. Lehmann, & Christoph U. Lehmann. (2002). The Interactive Patient: A Tool for Teaching Discriminating Data Collection in Therapeutic Problem Solving. 10(2). 35–45. 1 indexed citations

11.

Mullins, C. Daniel, Simu K. Thomas, & David S. Roffman. (2001). Pharmaceutical Restrictions. Disease Management & Health Outcomes. 9(2). 69–74. 1 indexed citations

12.

Reed, Shelby D., C. Daniel Mullins, David S. Roffman, & D. A. Mays. (1998). Difficulties in applying clinical trial information to the practice setting: Case of a high-cost drug. American Journal of Health-System Pharmacy. 55(22). 2409–2414. 1 indexed citations

13.

Gottlieb, Stephen S., et al.. (1998). The Effects of Diuresis on the Pharmacokinetics of the Loop Diuretics Furosemide and Torsemide in Patients with Heart Failure. The American Journal of Medicine. 104(6). 533–538. 36 indexed citations

14.

Applefeld, Mark M., et al.. (1987). Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients. American Heart Journal. 114(3). 589–595. 67 indexed citations

15.

Hassan, Erkan, David S. Roffman, & Mark M. Applefeld. (1987). The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failure. American Heart Journal. 113(3). 743–749. 16 indexed citations

16.

Applefeld, Mark M. & David S. Roffman. (1986). Digitalis and other positive catecholamine-like inotropic agents in the management of congestive heart failure. The American Journal of Medicine. 80(2). 40–45. 8 indexed citations

17.

Roffman, David S., et al.. (1985). Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.. PubMed. 4(2). 195–9. 28 indexed citations

18.

Applefeld, Mark M., Kathryn A. Newman, William R. Grove, et al.. (1983). Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. The American Journal of Cardiology. 51(3). 455–458. 59 indexed citations

19.

Applefeld, Mark M., Joseph Adir, William G. Crouthamel, & David S. Roffman. (1981). Digoxin Pharmacokinetics in Congestive Heart Failure. The Journal of Clinical Pharmacology. 21(2-3). 114–120. 10 indexed citations

20.

Roffman, David S.. (1980). Validation of Written Simulations as Measures of Problem Solving for Pharmacy Students. American Journal of Pharmaceutical Education. 44(1). 16–24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact